Ashton Thomas Private Wealth, LLC
Position in NAUT — Nautilus Biotechnology, Inc.
CIK 2019663
SCOTTSDALE, AZ
Position in NAUT
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$84,150
-$90,450 QoQ
Shares Held
45,000
0.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 93 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ashton Thomas Private Wealth, LLC holds $10,120,777 across 10 Biotechnology names. NAUT ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
35,756 | $4,053,300 | |
| 2 | EXEL |
Exelixis, Inc.
|
26,778 | $1,456,990 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,713 | $1,347,628 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
16,184 | $1,266,721 | |
| 5 | 37,458 | $1,177,304 | |||
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
1,704 | $538,617 | |
| 7 | CNSY |
Cerenome, Inc.
|
34,306 | $149,917 | |
| 8 | NAUT |
Nautilus Biotechnology, Inc.
This page
|
45,000 | $84,150 |
All Filings in NAUT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,150 | 45,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $174,600 | 45,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $87,750 | 45,000 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $38,025 | 45,000 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||